IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2020 Holdings

Filed 2020-05-18 | 13 holdings | $35.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$35.0M110,77199.2%
United Therapeutics Corp(UTHR)COM91307C102$51.2K539,6460.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$42.4K86,8170.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$41.5K462,1380.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$36.0K700,3180.1%
Taro Pharmaceutical IndusCOMM8737E108$29.8K487,2750.1%
Mckesson Corp(MCK)COM58155Q103$29.5K218,3060.1%
Alkermes PLC(ALKS)COMG01767105$16.8K1,167,6310.0%
Gilead Sciences Inc(GILD)COM375558103$8.8K117,7550.0%
RTI Surgical HDS IncCOM74975N105$6.9K4,027,7720.0%
Invacare CorpCOM461203101$6.6K887,2460.0%
Anaptysbio Inc(ANAB)COM032724106$6.3K443,8770.0%
Change Healthcare Inc(CHNGUSD)COM15912K100$363,6390.0%